Manulife (Manufacturers Life Insurance)’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$212K Sell
22,575
-353
-2% -$3.32K ﹤0.01% 2531
2025
Q1
$124K Sell
22,928
-48,310
-68% -$262K ﹤0.01% 2645
2024
Q4
$531K Buy
71,238
+3,657
+5% +$27.2K ﹤0.01% 2208
2024
Q3
$540K Sell
67,581
-462
-0.7% -$3.69K ﹤0.01% 2258
2024
Q2
$592K Sell
68,043
-8,496
-11% -$73.9K ﹤0.01% 2140
2024
Q1
$1.58M Buy
76,539
+2,118
+3% +$43.8K ﹤0.01% 1606
2023
Q4
$1.72M Buy
74,421
+21,482
+41% +$496K ﹤0.01% 1523
2023
Q3
$423K Buy
+52,939
New +$423K ﹤0.01% 2209
2022
Q4
Sell
-11,216
Closed -$88.7K 2971
2022
Q3
$88.7K Sell
11,216
-478
-4% -$3.78K ﹤0.01% 2841
2022
Q2
$92K Buy
+11,694
New +$92K ﹤0.01% 2932
2022
Q1
Sell
-11,490
Closed -$141 3105
2021
Q4
$141 Buy
11,490
+834
+8% +$10 ﹤0.01% 2998
2021
Q3
$111K Buy
+10,656
New +$111K ﹤0.01% 3094
2020
Q2
Sell
-4,272
Closed -$44K 2871
2020
Q1
$44K Buy
4,272
+1,174
+38% +$12.1K ﹤0.01% 2751
2019
Q4
$48K Buy
3,098
+1,177
+61% +$18.2K ﹤0.01% 2851
2019
Q3
$35K Buy
+1,921
New +$35K ﹤0.01% 2881